US Patent Issued to Bristol-Myers Squibb on Dec. 9 for "Glypican-3-binding fibronectin based scaffold molecules" (American, Canadian Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,492,238, issued on Dec. 9, was assigned to Bristol-Myers Squibb Co. (Princeton, N.J.).

"Glypican-3-binding fibronectin based scaffold molecules" was invented by Dasa Lipovsek (Pepperell, Mass.), Joseph Toth (Waltham, Mass.), Ginger C. Rakestraw (Somerville, Mass.), Irvith M. Carvajal (Brighton, Mass.), Stanley Richard Krystek Jr. (Ringoes, N.J.), Steven R. O'Neil (Wayland, Mass.), Guodong Chen (East Brunswick, N.J.), Richard Y. Huang (Bridgewater, N.J.), Bryan C. Barnhart (Vancouver, Canada), John Thomas Loffredo (Yardley, Pa.) and Christina Terragni (Wilmington, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are polypeptides which ...